Penserra Capital Management LLC Ovid Therapeutics Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$3.13 - $3.73 $4,867 - $5,800	-1,555 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.31 - $4.04 $33 - $40	10 Added 0.65%	1,555 $5,000
Q2 2021 Aug 12, 2021	BUY	$3.3 - $4.49 $346 - $471	105 Added 7.29%	1,545 $6,000
Q1 2021 May 13, 2021	SELL	$2.42 - $4.47 $36 - $67	-15 Reduced 1.03%	1,440 $5,000
Q4 2020 Feb 12, 2021	BUY	$2.28 - $6.84 $3,317 - $9,952	1,455 New	1,455 $3,000

43.2M

5.9K

300

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $52.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.